–(BUSINESS WIRE)–KeifeRx: WHAT: A Partner Spotlight conversation, “Advancing Neurodegenerative Disease Treatment: From Discovery to Patient Care,” featuring KeifeRx, a Georgetown University spinout developing disease-modifying medicines for dementia and other neurodegenerative diseases. KeifeRx is a Leadership Partner of the Summit. WHO: Chris Hoyt, CEO & Board Member, KeifeRx, in conversation with Sia Anagnostou, Summit Co-Chair and Head of Programming & Strategic Partnerships, The T

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.